BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22018640)

  • 1. Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages.
    Jinno Y; Nakakuki M; Kawano H; Notsu T; Mizuguchi K; Imada K
    Atherosclerosis; 2011 Dec; 219(2):566-72. PubMed ID: 22018640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass.
    Milosavljevic D; Kontush A; Griglio S; Le Naour G; Thillet J; Chapman MJ
    Biochim Biophys Acta; 2003 Feb; 1631(1):51-60. PubMed ID: 12573449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-590 attenuates lipid accumulation and pro-inflammatory cytokine secretion by targeting lipoprotein lipase gene in human THP-1 macrophages.
    He PP; Ouyang XP; Tang YY; Liao L; Wang ZB; Lv YC; Tian GP; Zhao GJ; Huang L; Yao F; Xie W; Tang YL; Chen WJ; Zhang M; Li Y; Wu JF; Peng J; Liu XY; Zheng XL; Yin WD; Tang CK
    Biochimie; 2014 Nov; 106():81-90. PubMed ID: 25149060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
    Li J; Li H; Wen YB; Li XW
    Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion.
    Tian GP; Chen WJ; He PP; Tang SL; Zhao GJ; Lv YC; Ouyang XP; Yin K; Wang PP; Cheng H; Chen Y; Huang SL; Fu Y; Zhang DW; Yin WD; Tang CK
    Biochimie; 2012 Dec; 94(12):2749-55. PubMed ID: 22963823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages.
    Lindqvist P; Ostlund-Lindqvist AM; Witztum JL; Steinberg D; Little JA
    J Biol Chem; 1983 Aug; 258(15):9086-92. PubMed ID: 6874679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
    Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein.
    Mizuguchi K; Yano T; Ishibashi M; Masada A; Mizota M; Saito Y
    Eur J Pharmacol; 1993 Apr; 235(2-3):221-7. PubMed ID: 8508903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low-density lipoprotein induces interleukin-1beta expression in macrophages.
    Stollenwerk MM; Lindholm MW; Pörn-Ares MI; Larsson A; Nilsson J; Ares MP
    Biochem Biophys Res Commun; 2005 Sep; 335(2):603-8. PubMed ID: 16087165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages.
    Palmer AM; Nova E; Anil E; Jackson K; Bateman P; Wolstencroft E; Williams CM; Yaqoob P
    Atherosclerosis; 2005 Jun; 180(2):233-44. PubMed ID: 15910848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia.
    Tanaka N; Ishida T; Nagao M; Mori T; Monguchi T; Sasaki M; Mori K; Kondo K; Nakajima H; Honjo T; Irino Y; Toh R; Shinohara M; Hirata K
    Atherosclerosis; 2014 Dec; 237(2):577-83. PubMed ID: 25463091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice.
    Matsumoto M; Sata M; Fukuda D; Tanaka K; Soma M; Hirata Y; Nagai R
    Atherosclerosis; 2008 Apr; 197(2):524-33. PubMed ID: 17765904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.
    Mason RP; Sherratt SC; Jacob RF
    J Cardiovasc Pharmacol; 2016 Jul; 68(1):33-40. PubMed ID: 26945158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosapentaenoic acid suppresses palmitate-induced cytokine production by modulating long-chain acyl-CoA synthetase 1 expression in human THP-1 macrophages.
    Nakakuki M; Kawano H; Notsu T; Imada K
    Atherosclerosis; 2013 Apr; 227(2):289-96. PubMed ID: 23433401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.